These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7719237)

  • 61. Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression.
    Xu K; Guidez F; Glasow A; Chung D; Petrie K; Stegmaier K; Wang KK; Zhang J; Jing Y; Zelent A; Waxman S
    Cancer Res; 2005 Sep; 65(17):7856-65. PubMed ID: 16140955
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effect of curcumin combined with ATRA on differentiation of ATRA-resistant acute promyelocytic leukemia cells].
    Chen TY; Xu F; Kong YY; Wen F; Xie FY; Wan LG; Zhang ZL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):895-8. PubMed ID: 23998581
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells].
    Guo W; Wang H; Zhao W
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):327-31. PubMed ID: 11798779
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of lipoxin A4 in the cell-to-cell interaction between all-trans retinoic acid-treated acute promyelocytic leukemic cells and alveolar macrophages.
    Tsai WH; Shih CH; Wu HY; Chien HY; Chiang YC; Lai SL; Hsu SC; Kou YR; Hsu HC
    J Cell Physiol; 2012 Mar; 227(3):1123-9. PubMed ID: 21567401
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA.
    Takeshita A; Shinjo K; Naito K; Ohnishi K; Sugimoto Y; Yamakawa Y; Tanimoto M; Kitamura K; Naoe T; Ohno R
    Br J Haematol; 2000 Jan; 108(1):90-2. PubMed ID: 10651729
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induction of differentiation in acute promyelocytic leukemia cells by 9-cis retinoic acid alpha-tocopherol ester (9-cis tretinoin tocoferil).
    Makishima M; Umesono K; Shudo K; Naoe T; Kishi K; Honma Y
    Blood; 1998 Jun; 91(12):4715-26. PubMed ID: 9616170
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases.
    Mologni L; Ponzanelli I; Bresciani F; Sardiello G; Bergamaschi D; Gianní M; Reichert U; Rambaldi A; Terao M; Garattini E
    Blood; 1999 Feb; 93(3):1045-61. PubMed ID: 9920855
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines.
    Rosenauer A; Raelson JV; Nervi C; Eydoux P; DeBlasio A; Miller WH
    Blood; 1996 Oct; 88(7):2671-82. PubMed ID: 8839862
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
    Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
    Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Everolimus combined with all-trans retinoid acid reverses drug resistance in acute promyelocytic leukemia NB4-R1 cells].
    Liao WC; He Y; Wang BS; Huang H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 44(5):525-31. PubMed ID: 26713527
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Retinoic acid receptors: involvement in acute promyelocytic leukemia.
    Agadir A; Cornic M; Gourmel B; Lefebvre P; Degos L; Chomienne C
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):263-74. PubMed ID: 7920173
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of the acute promyelocytic leukemia PML/RAR alpha protein on differentiation and survival of myeloid precursors.
    Fagioli M; Grignani F; Ferrucci PF; Alcalay M; Mencarelli A; Nicoletti I; Grignani F; Pelicci PG
    Leukemia; 1994 Apr; 8 Suppl 1():S7-11. PubMed ID: 8152308
    [TBL] [Abstract][Full Text] [Related]  

  • 73. All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias.
    Barber N; Belov L; Christopherson RI
    Leuk Res; 2008 Feb; 32(2):315-22. PubMed ID: 17561254
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tocotrienols-enriched Self-nanoemulsifying Drug Delivery System Enhances the Antileukemic Activity of All-trans Retinoic Acid but not Electrocardiogram Alterations Evoked by Its Combination with Arsenic Trioxide.
    Borges GSM; Sicard P; de Mello Gomides Loures C; Evangelista FGC; Sales CC; de Paula Sabino A; Fernandes C; Ferreira LAM; Richard S
    AAPS PharmSciTech; 2023 Mar; 24(3):79. PubMed ID: 36918482
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Realgar-induced apoptosis and differentiation in all-trans retinoic acid (ATRA)-sensitive NB4 and ATRA-resistant MR2 cells.
    Chen S; Fang Y; Ma L; Liu S; Li X
    Int J Oncol; 2012 Apr; 40(4):1089-96. PubMed ID: 22134377
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells.
    Jing Y; Xia L; Lu M; Waxman S
    Oncogene; 2003 Jun; 22(26):4083-91. PubMed ID: 12821942
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
    Gu BW; Xiong H; Zhou Y; Chen B; Wang L; Dong S; Yu ZY; Lu LF; Zhong M; Yin HF; Zhu GF; Huang W; Ren SX; Gallagher RE; Waxman S; Chen GQ; Wang ZG; Chen Z; Fu G; Chen SJ
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7640-5. PubMed ID: 12032336
    [TBL] [Abstract][Full Text] [Related]  

  • 78. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
    Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
    Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells.
    Albanesi J; Noguera NI; Banella C; Colangelo T; De Marinis E; Leone S; Palumbo O; Voso MT; Ascenzi P; Nervi C; Bianchi F; di Masi A
    Cells; 2020 Nov; 9(11):. PubMed ID: 33167477
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Establishment of a human acute promyelocytic leukemia-ascites model in SCID mice.
    Zhang SY; Zhu J; Chen GQ; Du XX; Lu LJ; Zhang Z; Zhong HJ; Chen HR; Wang ZY; Berger R; Lanotte M; Waxman S; Chen Z; Chen SJ
    Blood; 1996 Apr; 87(8):3404-9. PubMed ID: 8605358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.